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Abstract

Stimuli responsive polyelectrolyte nanoparticles have been developed for chemo-photothermal
destruction of breast cancer cells. This novel system, called layer by layer Lipo-graph (LBL Lipo-graph),
is composed of alternate layers of graphene oxide (GO) and graphene oxide conjugated poly (l-lysine)
(GO-PLL) deposited on cationic liposomes encapsulating doxorubicin. Various concentrations of GO and
GO-PLL were examined and the optimal LBL Lipo-graph was found to have a particle size of
267.9 ± 13 nm, zeta potential of +43.9 ± 6.9 mV and encapsulation efficiency of 86.4 ± 4.7%. The
morphology of LBL Lipo-graph was examined by cryogenic-transmission electron microscopy (CryoTEM), atomic force microcopy (AFM) and scanning electron microscopy (SEM). The buildup of LBL Lipograph was confirmed via ultraviolet-visible (UV–Vis) spectrophotometry, thermogravimetric analysis
(TGA) and differential scanning calorimetry (DSC) analysis. Infra-red (IR) response suggests that four
layers are sufficient to induce a gel-to-liquid phase transition in response to near infra-red (NIR) laser
irradiation. Light-matter interaction of LBL Lipo-graph was studied by calculating the absorption cross
section in the frequency domain by utilizing Fourier analysis. Drug release assay indicates that the LBL
Lipo-graph releases much faster in an acidic environment than a liposome control. A cytotoxicity assay
was conducted to prove the efficacy of LBL Lipo-graph to destroy MD-MB-231 cells in response to NIR
laser emission. Also, image stream flow cytometry and two photon microcopy provide supportive data
for the potential application of LBL Lipo-graph for photothermal therapy. Study results suggest the
novel dual-sensitive nanoparticles allow intracellular doxorubin delivery and respond to either acidic
environments or NIR excitation.

Statement of Significance

Stimuli sensitive hybrid nanoparticles have been synthesized using a layer-by-layer technique and
demonstrated for dual chemo-photothermal destruction of breast cancer cells. The hybrid
nanoparticles are composed of alternating layers of graphene oxide and graphene oxide conjugated
poly-l-lysine coating the surface of a thermosensitive cationic liposome containing doxorubicin as a
core. Data suggests that the hybrid nanoparticles may offer many advantages for chemo-photothermal
therapy. Advantages include a decrease of the initial burst release which may result in the reduction in
systemic toxicity, increase in pH responsivity around the tumor environment and improved NIR light
absorption.
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1. Introduction
Liposomes have been one of the most investigated drug delivery systems, especially in clinically
relevant cancer models.1,2 In recent years, important advances to improve the therapeutic effect and
targeting of administered drugs to cancer patients have been made.3,4,5,6 In particular, efficacy of
treatment is highly dependent on the presence of sufficient drug in the tumorigenic region.1,7 This, in
turn, is dependent on effective delivery via a high payload capacity, high cellular uptake, and also
programmed drug release.8 Recently, a layer-by-layer deposition method has been shown to be an
effective process to improve therapeutic efficacy of administrated liposomes.9,10,11
Layer-by-layer liposomal nanoparticles fabricated by deposition of alternate layers of charged
polyelectrolytes onto the liposomes is intriguing due to the high loading capacity, multi-functionality,
tailored drug release and stimuli-responsiveness that can be achieved using this design.12,13,14 Although
some studies have focused on the application of LBL assemblies in drug delivery, the main emphasis of
these studies is to fabricate barrier layers to control cargo release encapsulated in the core while fewer
attempts have been made to fabricate an LBL engineered system to target tumor and facilitate sitespecific triggered cargo release.14,15,16
A variety of stimuli sensitive LBL constructions have been reported to modify liposomes by using
polyethylene glycol-reprivatized nanotubes,17 nanogolds,18 magnetic nanoparticles.19 Among other
stimuli sensitive delivery vehicles, near infrared (NIR) light triggered drug release has some advantages
as light at this wavelength has its maximum penetration depth through the tissue, while the main
interaction of tissue and light is scattering.20,21,22 Thus, in recent years different types of photoabsorbers with NIR absorption have been investigated including gold nanorods,23,24,25,26,27 gold
nanoshells,28,29 carbon nanotubes30,31,32,33 and graphene oxide.34,35

Graphene oxide (GO) is a single layer of graphite with unique thermal, electrical and optical properties.
Graphene oxide is able to absorb NIR light due to the delocalization of the electron states, and light
absorption rapidly transformed into thermal energy.34,36,37,38 Hence, GO with a large number of surface
functional groups on the surface, low production cost and acceptable thermal conductivity, can be
considered as a versatile stimuli-triggered candidate for photothermal therapy.36,39,40,41,42,43 However,
only a few studies have been reported on the application of GO for photothermal therapy. Yang et al.,
studied the influence of size and surface chemistry of GO coated PEG on photothermal destruction of
cancer cells.39 Cheng et al., examined chemo-photothermal properties of PEGylated GO containing
doxorubicin on cancer cells.44
The interaction between graphene oxide and liposome was studied previously by Feng et al.45,46 They
studied the interaction between nondiamond, graphene oxide and carbon nanotube with zwitterionic
liposomes. They found that the absorption of carbon based materials to the surface of liposomes
neither induces drug leakage nor affect phase transition temperature.45 In another study by the same
group, they demonstrated that the absorption of DOPC and doxorubicin on the surface of graphene
oxide was orthogonal because doxorubicin and DOPC didn’t displace each other and the adsorption
capacity was dependent on the presence of other molecules.46
In the current studies, we sought to improve the bioavailability and also pharmacokinetic profile of
nanoparticles intended for tumorigenic delivery by combining the advantages of liposomes with a
layer-by-layer synthesis technique. We chose a combination of GO and GO-PLL as the respective
polycation and polyanionic alternating layers and thermosensitive cationic liposome containing
doxorubicin as a core to fabricate layer by layer architecture. Positively charged poly-l-lysine (PLL) is
known to improve the cellular uptake of the nanoparticles and if PLL is incorporated in the LBL
nanoparticles, they have the potential to advance clinical translation of the nanotechnology.47 NIR light
is absorbed by GO and GO-PLL and converted to heat. Photothermal energy is used to activate a liquid
phase transition temperature of the phospholipid membrane and lead to the release of the
encapsulated toxic cargo. The present study investigates the concentration required for layer-by-layer
fabrication of GO and GO-PLL on the liposomal core (LBL Lipo-graph) and their physiochemical
characterization. The light matter interaction was studied by calculation the cross section absorption of
LBL Lipo-graph at 808 nm pulse laser irradiation in the frequency domain by utilizing the Fourier
analysis. Cytotoxicity analysis of LBL Lipo-graph were performed on MD-MB-231 cell lines. The
interaction of LBL Lipo-graph with MD-MB-231 cell lines was analyzed by image stream flow cytometry
and confocal microcopy.

2. Materials and method
2.1. Materials

Graphene oxide was purchased from Graphene Supermarket (Reading, MA, USA). 1,2-dipalmitoyl-snglycerol-3-phosphatidylcholine (DPPC), cholesterol (Chol), 1 2-Dioleoyloxy-3-trimethylammonium
propane chloride (Dotap) and poly(l-lysine) (PLL, MW: 15,000–30,000) were obtained from Avanti Polar
Lipids Inc. (Alabaster, AL). Polyoxyethylene (20) stearyl ether (Brij 78), doxorubicin HCl (DOX), fetal
bovine serum (FBS), phosphate buffer saline (PBS), and Dulbecco's Modified Eagle Medium (DMEM)
and Cell Proliferation Reagent Kit I (MTT) were purchased from Sigma Aldrich (USA). Fluorescein-5Isothiocyanate (FITC) and Live/dead cellular viability assay kits were purchased from Thermo-Fisher. PE
(Lissamine Rhodamine B) was purchased from Avanti Polar Lipids Inc. Cell tracker green and DAPI (4′,6-

diamidino-2-phenylindole) were supplied from Molecular Probe Inc. Mounted media was obtained
from Vector Laboratories, CA. All other chemical agents utilized were analytical grade.

2.2. Methods
2.2.1. Preparation of GO and GO-PLL suspension

An aqueous GO suspension was probe sonicated for 3 h (100 W, 5 s on and 2 s off, Misonix, USA) to
achieve exfoliated GO nano-sheets. Then, GO-PLL was prepared by vigorous stirring of 8 mg of poly-llysine, 2 mg of GO, and 10 mg of KOH in 10 ml of distilled water at 70 °C for 24 h following by multiple
centrifugation steps with water to remove excess PLL and impurities. The GO-PLL formation was
confirmed using FTIR (Perkin Elmer, Waltham, MA, USA).

2.2.2. Fabrication of LBL Lipo-graph

Thermosensitive liposomal nanoparticles (Lipo) were prepared using a thin film hydration and pH
gradient loading method. Briefly, 60 µmol of lipid mixture composed of DPPC, Brij 78, Dotap and Chol
in a molar ratio of 66/4/20/10 were dissolved in the mixture of chloroform/methanol (3:1) in a round
bottom flask. Then the organic solvent was evaporated from the lipid phase under reduced pressure at
37 °C in a rotary evaporator (Buchi Labortechnik, Switzerland) to form a thin lipid film on the inside
flask wall. Then the resulting thin lipid film was hydrated using 200 mM phosphate buffer saline at
42 °C (pH = 4). Subsequently, the large multilayered vesicles in a final concentration of 20 µmol·ml−1
(i.e. 13.72 mg·ml−1) were extruded through a 100-nm polycarbonate filter using a mini-extruder
(Avanti Polar Lipids, Inc., Alabaster, USA) for 21 cycles. A transmembrane pH gradient across the
membrane was induced by exchanging external sulfate buffer with PBS solution using a dialysis bag
(MWCO of 10 kDa, BBI, Canada), pH = 8.4. DOX (Lipid·drug−1 = 20 (molar ratio)) was loaded into
liposome by incubating for 45 min at 37 °C while stirring. Subsequently free DOX was separated using
dialysis bag. All procedures were completed in a dark environment.
LBL Lipo-graph were fabricated by continuously coating the Lipo with series of polyelectrolyte
suspensions of GO and GO-PLL using a layer-by-layer assembly method mediated by ionic interaction.
In brief, 1 ml of 1 mg/ml of liposomes (containing DOX) were first coated by several anionic GO
concentrations ( = 1/2, 1/4, 1/8, 1/16 (mass ratio)) under constant magnetic stirring at 2000 rpm for
20 min followed by immediate sonication for another 10 min (Sonics, USA). Particles were then
subjected to centrifugation at several speeds (0, 2000, 5000, 7000, 13,000 rpm) for 15 min. The size,
polydispersity index (PDI), zeta potential and the percentage of sedimentation were analyzed in
sediment and supernatant portions at each speed to study LBL Lipo-graph behavior at each centrifuge
speed. To measure the percentage of liposomal sedimentation, the concentration of phospholipid was
determined by the Stewart assay.48
1 ml of single layer coated liposome (1 LBL Lipo-graph) was then coated with GO-PLL in different mass
ratio ((1-LBL Lipo-graph)/(GO-PLL) = 1/2, 1/1, 2/1) under constant stirring and sonication similar the
first layer. For fabricating a 3-LBL Lipo-graph, various mass ratios of GO to 2 LBL Lipo-graph ((2-LBL
Lipo-graph)/(GO) = 1/2, 1/1, 2/1, 4/1) were examined. The ultimate 4-LBL Lipo-graph were fabricated
by examining the different mass ratio ((3-LBL Lipo-graph)/(GO-PLL) = 4/1, 8/1, 16/1, 32/1).

Centrifugation was done as described above in each coating step. Fig. 1 shows a schematic illustration
of the process for the preparation of LBL Lipo-graph.

Fig. 1. Schematic representation of LBL Lipo-graph preparation by assembly of GO and GO-PLL onto a cationic
thermosensitive liposome.

2.2.3. Molecular weight measurement

The molecular weight of LBL Lipo-graph was determined by Zetasizer ZS (Malvern Instruments,
Malvern, UK) using static light scattering (SLS) technique as previously described by Sayari et al.49
Briefly, 5 different concentration of LBL Lipo-graph were prepared and the intensity of scatted light
was determined. The molecular weight was measured by using the relationship between the intensity
of scattered light and its size and molecular weight based on Rayleigh theory.50 The molecular weight
was determined in Da.

2.2.4. Size and zeta potential analysis of LbL Lipo-graph

The average diameter and surface charge of Lipo, LBL Lipo-graph, GO and GO-PLL were measured at
25 °C using a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). All data were calculated as the
average of at least triplicate measurements.

2.2.5. Morphology characterization

The morphology was characterized by cryo-transmission electron microscopy (cryoTEM), TEM, atomic
force microscopy (AFM), and scanning electron microscopy (SEM).
For Cryo-TEM study, a droplet sample was placed on a carbon coated grid (treated with plasma to
increase hydrophilicity) in a controlled humidity chamber (FEI Vitrobot). The grid was then blotted by
two piece of filter papers followed by plunging into liquid ethane. The grid was examined under TEM
(FEI Tecnai G2 F20, FEI Company, USA) at a voltage of 200 kV. In TEM analysis, a droplet of diluted
sample was placed onto a copper mesh grid and excess liquid removed with filter paper. The grids
were examined under TEM (FEI Tecnai, USA) at a voltage of 80 kV. For AFM, the samples were dried on
a mica substrate, and analysed by tapping mode AFM (SPM VEECO, USA).
For SEM, a droplet of samples were dried on copper grid and analysed under SEM (Hitachi S-5500
SEM/STEM, Japan) Instrument.

2.2.6. UV vis spectroscopy

LBL Lipo-graph were analyzed using UV–vis spectroscopy (Infinite M200, Tecan Systems Inc., USA).

2.2.7. Thermal analysis

Thermogravimetric analysis (TGA) was carried out using thermogravimetric analyzer (TGA Q500, TA
Instruments, Delaware, US). The samples were heated from room temperature to 600 °C at a ramp
rate of 10 °C/min, the data were analyzed by TA instrument software. Differential scanning calorimetry
(DSC) thermograms were obtained by loading the samples into an aluminum pan and subjected to the
heat cycle in a differential scanning calorimeter (DSC Q2000, TA Instruments, Delaware, US) at a ramp
rate of 10°C/min from 0 to 100 °C. All the cycles were operated under a nitrogen gas atmosphere.

2.2.8. Drug loading efficiency and in vitro drug release kinetics

DOX encapsulation efficiency were determined by UV–Vis spectroscopy (Infinite M200, Tecan Systems
Inc., CA, USA) at 478 nm and after complete solubilizing of Lipo by Triton X-100.
The DOX release kinetics from Liposome and LBL Lipo-graph were studied at 37, 40 and 42 °C by
Mariska et al.51 method with modification. A 200 µl of sample was diluted to 800 µl of PBS at desired
temperature and were immediately incubated in 10 ml preheated PBS at 37 °C (for 24 h), 40 °C (for
30 min), and 42 °C (for 30 min) with constant stirring at 200 rpm. At each time intervals 200 µl of the
medium was withdrawn and compensated by a preheated fresh medium. The DOX concentration in
the samples were analyzed by UV–Vis spectroscopy at 478 nm. Also, we study the effect of pH on drug
release by monitoring cumulative drug release over 24 h in PBS (pH = 7.4) and acetate-buffered saline
(pH = 5.4).

2.2.9. Storage stability

Storage stability of the LBL Lipo-graph was tested at 4 °C for a week. Parameters including the zeta
potential, particle size and encapsulation efficiency were evaluated.

2.2.10. LBL Lipo-graph photothermal response

LBL Lipo-graph with different layers (400 µl, 1 mg·ml−1) were transferred in 96-well plate. An 808 nm
diode laser with power density of (0.5, 1 and 1.5 W·cm−2) was applied to the samples. Increasing

temperature in response to laser irradiation with a 6 mm diameter laser spot was monitored with an
InSb IR camera positioned above the sample. A laser diode controller (Thorlabs, Inc., LDC 240C)
regulated the diode current and a temperature controller (Thorlabs, Inc., TED 200C) fixed the emission
wavelength of the laser diode. The 808 nm laser light was coupled into a multimode optical fiber
(Thorlabs BFL48-1000). Light emitted from the tip of the fiber was imaged to a 6 mm diameter circular
spot using an aspherical lens (f = 20 mm). The temperature was measured using a temperature
calibrated InSb IR camera (FLIR systems, Inc., SC4000 MWIR).

2.2.11. Calculation of absorption cross section

The experimental setup used to measure absorption cross section of LBL Lipo-graph consists of a laser
diode coupling into an optical fiber (Thorlabs BFL48-1000, USA) and emitting at 808 nm. Controllers
(Thorlabs, Inc., LDC 240C and TED 200C, USA) fix current and temperature (i.e. emission wavelength) of
the laser diode. Output of the multimode fiber was directed into a spherical lens (f = 20 mm) to give a
6 mm diameter spot on the surface of LBL Lipo-graph suspension. The temperature of the suspension
was recorded using InSb IR camera (FLIR systems, Inc., SC4000 MWIR, USA). Acquisition control signals
for IR camera frame acquisition and diode power modulation were provided by a function generator
(Agilent 33250A and Berkeley Nucleonics Corp., USA) and a digital delay generator (Stanford Research
Systems, Inc., DG535, USA).
To mitigate the effects of lateral thermal diffusion, a time series of radiometric images were recorded
by the IR camera at various GO concentrations (0.25, 0.125, and 0.0625 mg·ml−1), GO-PLL (0.1, 0.15,
and 0.2 mg·ml−1), and 4 LBL Lipo-graph (0.1, 0.2, and 0.3 mg·ml−1) placed in 96 well-plate and
compared to the corresponding profile of a standard black (at 808 nm) absorber. After emission of a
25 ms pulsed laser, the first radiometric image of each samples was selected to compare the variation
of the surface temperature along a diameter in the beam profile. Since the temperature profile has
azimuthal symmetry, the radiometric emission profile across the beam diameter was fitted to Gaussian
curve. The sample with a similar profile to the standard black paper was chosen for following
calculation of absorption cross section. Calculation the cross section absorption of GO and rGO-Arg was
already set up by Hashemi et al.52

2.2.12. In vitro photothermal response

Chemo-photothermal therapy potential of LBL Lipo-graph on MD-MB-231 cell lines were evaluated
using MTT and live/dead assays. MD-MB-231 cells were seeded at a density of 50,000 cells/well in 96well plate overnight. Then, the medium was replaced with fresh medium (composed of complete
DMEM) containing different DOX concentration (0,1.25, 2.5, 5, 10 µg·ml−1) in the form of free DOX,
Lipo, LBL Lipo-graph and then the plates were incubated for another 24 h. After that, cells in the laser
group were exposed to NIR light (1.5 W·cm−2 with 6 mm spot size) radiation for 5 min. Then cell
viability was determined by MTT assay. Briefly, 10 µl of MTT solution (5 mg·ml−1) was added to each
well and incubated for 4 h. Then, 200 µl of dimethyl sulfoxide was added to each well plate and were
allowed to shake for 20 min to dissolve formazan crystal.53 The optical density of each well plate was
read at 570 nm with background subtraction at 690 nm by a Tecan microplate reader (Infinite M200,
Tecan Systems Inc., USA). The viability of cells was calculated by the following formula:

mean viability =

mean absorbance value of treatment group − blank
× 100
𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 − blank

To visualize the effect of chemo-photothermal potential of LBL Lipo-graph, MD-MB-231 cells were
stained by live/dead assay. Cell lines were seeded at a density of 50,000 cells/well in 96-well plates and
incubated for 24 h prior to use. Then, cells were treated with 100 µl of LBL Lipo graph (100 µg·ml−1 of
DOX) for 24 h followed by 3 times PBS washing and then exposed to NIR pulsed laser irradiation (5 min,
1 W·cm−2). After incubation for another hour, cells were stained using ethidium homodimer-1 (EthD–
1) (4 M) and calcein AM (2 M) for 15 min at room temperature. Calcein AM is converted to fluorescent
calcein (excitation ∼495 nm, emission ∼515 nm) by intracellular esterases present in live cells. EthD–1
penetrates the damaged cell membrane and binds to the nucleic acids (excitation ∼496 nm, emission
∼635 nm). All fluorescent images were recorded using an inverted fluorescent microscope (Evos, Life
Technologies).

2.2.13. Cell association profile with LBL Lipo-graph

The percentage of cells interacting with LBL Lipo-graph and the average number of LBL Lipo-graphs per
cell were analyzed by image stream flow cytometry. MD-MB-231 cell lines with density of 105 cell/well
were seeded into 48-well plates for 24 h. Then, cell lines were treated with LBL Lipo-graph
encapsulated FITC at a concentration of 2 × 104 LBL Lipo-graph/µl. At time intervals of 0, 1.5, 3, 6, 9
and 24 h, cells were washed with cold PBS and then were harvested by trypsinization followed by
centrifugation at 4000 rpm for 5 min. The cells were resuspended in PBS and analyzed by image stream
flow cytometry (Amnis Corporation, Seattle). At each time interval, at least 5000 cells were acquired
and analysis was carried out only on focused cells. The fluorescent intensity arising from associated
encapsulated FITC and bright filed images related to the individual cells were recorded using the
extended depth of field collection mode. The data were analyzed using IDEAS software (Amnis
Corporation, Seattle) to detect the number of capsules per cell.

2.2.14. LBL Lipo-graph internalization evaluation

Samples were prepared as mentioned above. Briefly, cells were treated with capsule as a ratio similar
to that described above for 24 h. The cells were harvested at each time interval and resuspended in
PBS for image stream flow cytometry analysis (Amnis Corporation, Seattle). Images of 5000 cells and
their fluorescent intensity of FITC encapsulated in nanoparticles were recorded. The internalization
analysis was performed on 200 focused single cells. IDEAS software was used to create a mask
according to the bright field image and then the built-in internalization features were used to calculate
the internalization score.

2.2.15. Confocal microscopy

Intracellular uptake of LBL Lipo-graph into MD-MB-231 cell lines was studied by confocal microscopy
(Prairie Technologies, Inc). The cells were seeded in a 6-well plate at a density of 2 × 105 cell/well for
24 h. Then cells were incubated with LBL Lipo-graph containing rhodamine PE (1% molar ratio) for 0,
1.5, 3, 6, 9 and 24 h. Then, cells were stained with cell tracker green fluorescent probe at a
concentration of 4 μM in DMSO for 15 min, followed by 3× PBS washes. Then cells were fixed in 4%
paraformaldehyde in PBS for 1 h. After that, nuclei were stained for 15 min using 100 μl of 0.1 μg·m−1
of Dapi followed by 3× PBS washes. Cells were mounted in medium overnight at room temperature.
Morphological features were observed under confocal microscopy (Prairie Technologies, Inc).

2.2.16. Statistical analysis

The results were evaluated statistically using one-way analysis of variance (ANOVA) followed by
Tukey’s pairwise test at (P ≤ 0.05). All data were expressed as the mean ± standard deviation (SD).

3. Results and discussion
3.1. Characterization of GO and GO-PLL and uncoated liposome

Lysolipid (MSPC) containing thermosensitive liposome is one of the most studied of thermo-responsive
liposomal formulations.54,55 With this formulation, the presence of lysolipid can effectively increase the
rate of drug release.56 However, in vivo administration of this formulation exhibited desorption of
lysolipids from the liposomal formulation into the biological media and also creates a defect in the
bilayer which caused undesirable drug release at physiological temperature during blood circulation.57
As a solution, a new formulation composed of Brij 78 surfactant which is substituting DSPE-PEG 2000
and MSPC functionality has been developed by Tagami et al.54 Although, this formulation which
composed of DPPC/Brij 78 (96/4) increased 40% drug release in comparison with lysolipid containing
thermosensitive liposome, the absence of cholesterol decreased the stability of liposome during blood
circulation and shelf life.58,59 Herein we used Brij 78 to substitute the functionality of MSPC and DSPEPEG 2000, cholesterol to increase the stability of the liposomes and Dotap to create a cationic
liposome. As shown in a recorded DSC thermogram (Fig. 4B), our formulation can be considered as a
thermosensitive liposome.
Prior to coating the liposomes with GO and GO-PLL, particle size and zeta potential of GO, GO-PLL and
liposome suspension were characterized using dynamic light scattering. As shown in Fig. 1 and Table 1,
the liposome size distribution was monomodal with an average z diameter of 138.8 nm and a low
polydispersity index of 0.12. Zeta potential measurement showed that liposomes and GO carried a
charge of 52.7 ± 11.1 mV and −53.7 ± 10.4 mV, respectively. After successful conjugation of PLL to GO
(see FTIR spectrum in Fig. S1) via the primary amine group of PLL and epoxy group of GO, the zeta
potential of GO-PLL inverted to +50.87 ± 9.6 mV. The initial positive charge of the liposomal surface
makes it a good candidate for coating with negatively charged graphene oxide. Also, the inverse charge
of GO and GO-PLL make them suitable candidates for layer-by-layer construction over the cationic
thermosensitive liposome.

Table 1. (A) Optimization of GO or GO-PLL/n LBL Lipo-graph gram ratio, (B) converting the gram ratio of
GO and Liposome in single layer coated liposome to molar ratio.

Since the fabrication of LBL Lipo-graph was dependent on the electrostatic interaction of the
compartments, effect of ionic strength and pH value of the working solution were examined (Fig. S2).
As shown in Fig. S2A, increasing the ionic strength decreasing the electrostatic absorption force
between the GO and GO-PLL sheets which was confirmed by monitoring the zeta potential values of
GO and GO-PLL at different ionic strengths. By increasing NaCl concentration, the zeta potential
decreased for both GO and GO-PLL. As shown in Fig. S2A, increasing the NaCl concentration from 0 to
10 mmol·L−1 lead to a significant change in zeta potential values while further increases in NaCl
concentration didn’t effectively change the zeta potential. As shown in Fig. S2, to further investigate
the effect of protonation and deprotonation on the electrostatic interaction, the effect of pH on zeta
potential of GO, GO-PLL and cationic liposome at the same ionic concentration (10 mmol·L−1 NaCl) has
been monitored. The data suggests that pH strongly impacts the surface charge density. Due to the
protonation of GO sheets at lower pH and deprotonation of GO-PLL sheets at higher pH the zeta
potential changed significantly at lower and higher pH for GO and GO-PLL, respectively.
Since the large difference in zeta potential values is expected to impact electrostatic interactions while
using the ionic working solution increases the repeatability of the electrostatic dependent fabrication
process, 10 mmol·L−1 NaCl at pH=7.4 was selected as a working solution. Our result is consistent with
previously reported results.60,61

3.2. LbL Lipo-graph assembly: Static light scattering (SLS), dynamic light
scattering (DLS) and zeta potential analysis

Sequential GO and GO-PLL nano-sheets were assembled directly on the surface of cationic liposomes
to construct the LBL Lipo-graph. GO was selected as the polyanionic species due to the high negative
charge density and biocompatibility. Analogously, GO-PLL was selected due to its high positive charge
density, biocompatibility and cell adhesion property.62 For fabrication of multilayered GO and GO-PLL
structures, at each step, the surface must reach an opposite charge of sufficiently high magnitude to
assure that the following layer is appropriately attracted to the surface. The principle of the overall
approach is represented in Fig. 1 as the zeta potential and size of the uncoated liposome, GO and GOPLL. In the present study, we showed that carful adjustment of GO and GO-PLL ratios played a
significant role in the formation of LBL Lipo-graph. So, in each layer formation during LBL construction,
several concentrations of GO or GO-PLL to liposome has been studied (Table 1) and the zeta potential
and z average diameter of the fabricated nanoparticle has been measured.
Since the zeta potential of the liposomes were initially positive due to the presence of positively
charged Dotap in the liposomal formulation we first deposited GO onto the liposome. Different GO/
Liposome mass ratios (1/16, 1/8, 1/4, 1/2, 1/1) have been examined to find an appropriate
concentration of GO. As shown in Table 1, the GO/Lipo = 1/16 and 1/8 wasn’t sufficient to invert the
positively charge of a cationic liposome to a negative charge. While a number ratio of GO/Lipo = 1/4
caused aggregation (Supplementary 4).
At the mass ratio of GO/Lipo = 1/2 and 1/1, positively charged liposomes inverted to negatively
charged in 1-LBL Lipo-graph indicating covering of the liposome surface with GO. Based on a
calculation (Supplementary 3), the necessary molar ratio of GO/Lipo to completely cover a liposome is
3, so the mass ratio of GO/Lipo = 1/1 was selected as the appropriate concentration for coating the
liposome. As shown in Table 1, with increasing the mass ratio of GO the zeta potential decreased while
the z average diameter increased.

To deposit a second layer, GO-PLL at a different mass ratio (GO-PLL/ 1-LBL Lipo-graph = 1/2, 1/1, and
2/1) was selected. The ratio of GO-PLL/1-LBL Lipo-graph=1/2 formed aggregation in the medium. This
aggregation could be related to the concentration at which the sum of all positive and negative charges
at the shear plane of the fabricated structure is zero or it may be related to the presence of equal
numbers of positive (Liposome and GO-PLL) and negative (GO) particles in solution.63
By using the same mass ratio of GO-PLL and 1-LBL Lipo-graph, the z average diameter was decreased
and the colour of the suspension also turned into lighter tonalities (data not shown). It could be related
to the strong electrostatic attraction between the GO-PLL and GO that apparently led to a loss of
integrity between the outer layer which is a severe destabilization. The mass ratio of GO-PLL/1-LBL
Lipo-graph = 2/1 has been chosen for coating in the subsequent steps.
For third and fourth layer formations several ratios of GO and GO-PLL to fabricated an LBL Lipo-graph
has been examined (Table 1). Some ratios of GO or GO-PLL thus make big aggregation. The green box
shows the concentration of GO or GO-PLL which cause detach of the underlying layer and blue box
shows the selected concentration.
DLS analysis indicates that LBL Lipo-graph was accompanied by reaching a final size of 267.9 nm after
assembly of 4 layers. The large increase in LBL Lipo-graph size after construction of 4 layers maybe
related to the thick interface on the liposome surface or a disordered assembly of GO and GO-PLL.
Also, SLS measurements showed that the molecular weight of Lipo-graph gradually increased by
increasing the number of layers. The molecular weight of liposome, 1-LBL Lipo-graph, 2-LBL Lipo-graph,
3-LBL Lipo-graph and 4-LBL Lipo-graph was 119263 ± 10283, 452649 ± 39268, 1384842 ± 147591, and
1720382 ± 196393, 2168485 ± 246839 kDa. Large molecular weight of the fabricated LBL Lipo-graph
lead to the presence of large sheets of GO and GO-PLL. The variation observed in SLS data were related
to the presence of the giant molecules of LBL Lipo-graph and also presence of 2-D nanosheets of GO
and Go-PLL which assumed as a spherical structure.64

3.3. Optimization of centrifuge speed

Centrifuge speed is considered as an important parameter during construction of LBL Lipo-graphs to
separate aggregated nanoparticles from assembled LBL Lipo-graph. As shown in Fig. 2, the effect of
centrifuge speed on z average diameter, polydispersity index, zeta potential and nanoparticle
sedimentation were analyzed in sediment and supernatant portions of microtube after each layer
formation.

Fig. 2. The effect of centrifuge speed on (A) z average diameter, (B) PDI, and (C) Zeta potential of the
nanoparticles in supernatant and sediment portion per layer formation, (D) the percentage of liposomal
sedimentation per layer formation during centrifugation. Changes in (E) z average diameter, and (F) zeta
potential with the addition of each polyelectrolyte layer on the cationic liposome.

In the supernatant, the size of an LBL Lipo-graph decreased with increased centrifuge speed while in
the sediment portion the size of nanoparticle increased after each layer formation. Without
centrifugation, size of 1-LBL Lipo-graph was 289.5 ± 5.2 nm, which is larger than the size of individual
liposomes and graphene oxide and shows the electrostatic attachment of some liposomes and
graphene oxide. High polydispersity index (PDI) (0.45, Fig. 2B) of 1-LBL Lipo-graph shows a large
variability in particle size.
At 5000 rpm, size and PDI of 1-LBL Lipo-graph in supernatant was around 175.3 ± 4.3 nm and 0.12,
respectively indicating that the centrifuge speed is sufficient to separate the aggregated nanoparticles
from the assembled ones. As shown in Fig. 2A, B, and D since the centrifuge speed need to be as low as
possible to prevent sedimentation of desired assembled LBL Lipo-graph, 5000 rpm was selected for
subsequent coating steps.
As shown in Fig. 2C, no significant change in zeta potential was observed by increasing the centrifuge
speed in the supernatant portion, while in the sediment portion after 13,000 rpm, the zeta potential
was almost close to zero specially after deposition of the fourth layer. Two possible explanations are
offered for this observation. One possibility is that LBL Lipo-graph was not sufficiently stable at 13000
rpm centrifugation and lead to the formation of large aggregation composed of 56.5 ± 5% liposomes
(Fig. 2D).65 A second possibility is that during high speed centrifugation, the layer-by-layer formation

structure breaks apart and GO coat charged group existing on the surface of GO-PLL and cationic
liposome.66,67
Fig. 2D represent the results of the Stewart assay to analyze the liposomal sedimentation during
centrifugation. At a 5000 rpm centrifuge speed, in the first layer formation, around 43.7% of
nanoparticles were aggregated, while after coating the second layer 36.65% of nanoparticles were
aggregated. After third and fourth layer formation, 35.6% and 24.2% of nanoparticles were aggregated,
respectively. In other word during LBL construction almost 17.36% of liposomes were coated by GO
and GO-PLL.
As discussed previously, DLS analysis indicates that LBL Lipo-graph was accompanied by a gradual
increase in particle size reaching a final z average diameter of 253.4 nm and polydispersity index of
0.17 (Fig. 2E). As shown in Fig. 2F, LBL assembly was attended by a reversal of surface charge. An
inversion in the LBL Lipo-graph surface charge was observed after each layer formation. However,
since important functional groups such as carboxyl and amine were involved in electrostatic interaction
during LBL assembly, it is likely that free functional groups were still available for further modification
of the LBL Lipo-graph due to the high surface charge density of 4-LBL Lipo-graphs.68,69

3.4. Morphology analysis

To estimate whether liposomes were coated with GO and GO-PLL and to study the structural
morphology of liposome and LBL Lipo-graph, TEM, AFM and SEM images of the samples were recorded
(Fig. 3). Based on recorded AFM images, liposomes (Fig. 3A) are more uniform than LBL Lipo-graph (Fig.
3C) which is consistent with the results reported by Weilin et al.,70 and Ye et al.71 Although, as clearly
shown in Fig. 3D image, thickness of the nanoparticles increased during layer-by-layer construction
(around 130 nm based on DLS and AFM results) while the individual spherical structure were
unchanged. As shown in Fig. 3(D–H) Cryo-TEM photographs are consistent with AFM images and
indicate that the layer-by-layer assembly of GO and GO-PLL on the liposomes doesn’t alter the
spherical shape. Furthermore, cryo-TEM size measurement is consistent with DLS data. The size of 1LBL Lipo-graph slightly increased after the deposition of the first layer but maintained a spherical nonaggregated morphology (Fig. 3E and F). Thickness of GO coated liposome is about 16 nm (Fig. 3H)
which is nearly equal to the value observed by DLS (∼18.5 nm). Due to liposome surface curvature, the
assembled graphene oxide tilted, so the electron transmission path is more obstructed at the edge in
comparison to the center where graphene oxide is flat (see Fig. 3I and J), so a dark ring was observed in
the 1-LBL Lipo-graph (Fig. 3F). Fig. 3E shows a partial GO liposome coating. Further layer addition
resulted in the formation of dark and large particles (Fig. 3G). Although the individual layers could not
be distinguished because of the electrostatic attachment of GO and GO-PLL, formation of round dark
particles show the assemblage of multilayer GO and GO-PLL on the liposome surface which blocked the
transmission path (Fig. 3G). The results suggest that two-dimensional GO and GO-PLL structures can
completely coat the liposomal surface.

Fig. 3. AFM image of A) liposome, B) partial coated liposome, C) 4-LBL Lipo-graph. Cryo-TEM image of D)
liposome, E) partial coated liposome, F) 1-LBL Lipo-graph, G) 4-LBL Lipo-graph, H) magnification of F to
determine the thickness of the first layer coated liposome. TEM image of I) GO and J) GO-PLL. SEM image of K)
and L) 4-LBL Lipo-graph, M) liposome, N) GO and O) multilayer GO-PLL.

Surface texture and morphology of LBL Lipo-graph nanoparticles were further confirmed by SEM
imaging (Fig. 3K and L). Sucrose was used as a cryoprotectant to maintain nanoparticle morphology. As
shown in Fig. 3. K, L and M liposome and LBL Lipo-graph are spherical, but as mentioned previously LBL
Lipo-graphs are less uniform than liposomes. LBL Lipo-graph exhibits rarely smooth surface
morphological structure leading to the non-uniform assembly of GO (Fig. 3N) and GO-PLL (Fig. 3O). Due

to nanoparticle shrinkage during drying, the difference between 2rd, 3rd, and 4rd layers of GO and GOPLL could not be distinguished in SEM images.

3.5. Physical characterization

To investigate the photothermal potential of GO and GO-PLL, the optical absorption spectra were
examined. GO displayed a strong absorption picks at ∼233 and ∼305 nm (Fig. S4) which are the
characteristic absorption features of π-π∗ transition of aromatic carbon bonds and n-π∗ transition of
carbonyl bonds,72 respectively. After conjugation with PLL, the optical absorption increased over the
entire UV–Vis spectral range representing the partial restoration of a π-network of electrically
insulated GO.60 As shown in Fig. 4A, due to the prominent absorbance for both GO and GO-PLL in the
UV/Vis region the absorption strength gradually increased with each successive layer addition.

Fig. 4. (A) The absorption spectra of different particles (the inset is a plot of absorbance at 808 nm vs. the
number of layers). (B) DSC and (C) TGA thermogram monitored during layer by layer construction on the
thermosensitive liposome (inset is a TGA thermogram of liposome, GO, GO-PLL and PLL). Drug release assay (D)
over 24 h at pH = 5.2 and pH = 7.4 and (E) during mild hyperthermia (T = 40, 42 °C) over 20 min (the inset picture
is the effect of temperature on the amount of drug release over 20 min).

Furthermore, the absorption cross section of 4-LBL Lipo-graph at 808 nm as an important property to
determine the ability of the photothermal transducer to absorb incident light has been calculated (see
Supplementary 6).73 To measure the absorption cross section, the effect of heat loss through the

lateral part of the sample holder was minimized by using pulse laser mode with pulse duration of 0.5 s
(50% duty cycle). Then, the effect of scattering was minimized by optimizing the concentration of LBL
Lipo-graph. After that, the absorption cross section was determined in the frequency domain (Fig. S5).
As shown in Table S1, the absorption cross section of 4-LBL Lipo-graph is 1.47 ± 0.1 [ml/(mg·cm)].
The results suggest that the absorption cross section of 4 LBL Lipo-graph is decreased compared to GO,
due to the presence of high molecular weight phospholipid in the structure. However, the absorption
cross section of 4 LBL Lipo-graph is increased as compared to bare liposome (near 0 [ml/mg·cm], data
not shown).
DSC provided useful information regarding the thermotropic properties of nanoparticles following
polyelectrolyte deposition by subjecting samples to a thermal cycle of heating and cooling.
Thermotropic phase transitions of pure DPPC corresponds to the constant enthalpy value and melting
of an acyl chain. In general, adding polymer can either increase or decrease the phase transition
temperature of the main phospholipid, depending on whether it interacts with the acyl chain or polar
head of phospholipid74 and also the melting point of the main phospholipid. Our intact liposome
exhibits a higher phase transition temperature (Tm = 43.29 °C) than that of pure DPPC (Tm = 39.9 °C).
Although the presence of Dotap and cholesterol shift the phase transition temperature to the higher
values,75,76 Brij 78 decreased the phase temperature to lower values.54 Importantly, the phase
transition temperature slightly shifts to higher values following layer-by-layer deposition (Fig. 4B). The
Tm peak broadening will increase with the number of layers and exhibit the deposition of thin layers of
complementary materials on the liposome surface. A similar result was reported by Thiruganesh et
al.15 during sequential deposition of poly(ethylene glycol)-block-poly(l-aspartic acid) and poly-l-lysine
on the liposomal nanoparticles. Since the melting point of pure cholesterol and Dotap is above
100 °C,75,76 we suggest that the second peak in the DSC thermogram may be related to the total
dissolution of the liposomal compartment.
Moreover, TGA was applied to evaluate the organic component in GO, GO-PLL and following
assemblage of GO and GO-PLL on the liposomal nanoparticles (Fig. 4C). As shown in inset picture of Fig.
4C, in PLL the two-large shoulders on the thermal degradation curve mainly rise in around 150 and
300 °C. The plot shows a little weight loss less than 100 °C, 45% weight loss between 150 and 270 °C
corresponding to the melting of PLL and a final weight loss is observed around 300 °C.77 While for GOPLL, up to 100 °C, the amount of weight loss is about 4% higher than GO and may lead to the
incomplete drying process which attributed to the presence of heavy chain of poly(l-lysine) in the GO
structure. Furthermore, in the range of 100–200 °C, GO-PLL and GO show 26% and 34% weight loss,
respectively. The weight loss in the temperature range of 100-200°C is mainly related to the presence
of labile oxygen in GO and GO-PLL., Conjugation of PLL to GO decreased the amount of labile oxygen in
GO-PLL structures.77,78,79 21% of the weight loss between 300 and 400 °C in the GO-PLL may be related
to the evaporation of the large portion of PLL.77 Above 350 °C, GO exhibits 13% more weight loss than
GO-PLL that lead to the carbon pyrolization.77,78,79 Comparing the slopes of the TGA curves for GO and
GO-PLL in the temperature range from 50 to 200 °C, the decomposition rate of GO-PLL is clearly much
slower, suggesting the role of the electrostatic interaction between GO and GO-PLL. Comparing the
TGA thermograph of GO and GO-PLL, GO-PLL has better stability especially at temperatures higher
than 400°C. As shown in Fig. 4C (inset picture) in the liposomal nanoparticles, weight loss till 100 °C
corresponding to the moisture and probably the presence of Brij 78 in the structure. The main weight
loss between 200 and 350 °C could be due to the whole liposomal decomposition.

Fig. 4C indicates that the amount of moisture in the 1-LBL Lipo-graph is similar to the individual
liposome which evaporates up to 100°C while by increasing the number of layers the moisture residue
increases between layers. Weight loss in the temperature range of 100–200 °C is around 14–16% and it
didn’t change significantly by increasing the number of layers; the weight loss in this temperature
range is probably related to the volatile oxygen corresponding to the presence of GO and PLL. The
weight loss between 200 and 350 °C for 3-LBL Lipo-graph and 4-LBL Lipo-graph is around 18–19% while
the weight loss for 1-LBL Lipo-graph and 2-LBL Lipo-graph is around 49–51%. Since the weight loss at
this range corresponds to lipid evaporation, the stability of LBL Lipo-graph increases after adding third
and fourth layers of GO and GO-PLL. The weight loss at temperatures above 350 °C for 1-LBL Lipograph and 2-LBL Lipo-graph are around 14–16% while for 3-LBL Lipo-graph and 4-LBL Lipo-graph are
around 38–40%. This may be related to the presence of large amounts of GO on the particle.

3.6. Drug loading and release assay

DOX (𝐿𝐿/𝐷𝐷 = 1/20), was loaded into the cationic liposomes using the pH gradient method between
interior of the liposomes and the buffer solution, resulting in DOX protonation inside the acidic interior
and reaching high encapsulation efficiency of DOX (86.4 ± 4.7%). By comparison to control blank
liposomes, DOX loading was accompanied by a slight increased zeta potential and z average diameter,
52.7 ± 11.1 to 56.8 ± 10 mV and 138.8 ± 3.6 to 142.8 ± 2.8 nm, respectively. Also, by comparing DOX
encapsulation efficiency before and after of LBL formation, it seems that DOX entrapment efficiency
remained intact during layer-by-layer construction.
In vitro DOX release profiles from both liposome and 4-LBL Lipo-graph were evaluated in neutral
(pH = 7.4) and acidic media (pH = 5.2) as shown in Fig. 4D. Liposomes displayed biphasic release
kinetics with 22.48 ± 1.67% drug release at pH = 7.4 over the first 8 h followed by sustained release
over the next 16 h. In contrast, LBL Lipo-graph exhibited less initial burst release at pH = 7.4
(17.85 ± 1.71%). The faster drug release from liposomal nanoparticles might be due to the high
hydrophilicity of DOX and shorter path length for diffusion into the release media. In addition, the
strong polyelectrolyte effectively control drug release rate at physiologic pH environments.15 Since
tumors often generate an acidic environment, release profiles from the nanoparticles at acidic pH is
important. As shown in Fig. 4D, DOX release from both liposome and LBL Lipo-graph were higher in an
acidic extra-vesicular environment. The acidic release effect may be related to the protonation of
phosphate salt by pH shifts from 7.4 to 5.2. This results in a weak interaction between DOX and
phosphate salts and lower stability of DOX inside the liposome. Similar results were observed by other
investigators.80,81,82,83 Furthermore, the present study found that DOX release rate from LBL Lipo-graph
at pH = 5.2 is 7.02 ± 0.47% faster than liposomes indicating disassembly of the shells around the
liposomes. Data suggests that GO has been mildly protonated (see Supplementary 1) at pH = 5.2 and
this decreased the charge density for interaction with GO-PLL resulting in shell disassembly.84
To examine the effect of layer-by-layer assembly on thermo-responsivity of LBL Lipo-graph
nanoparticles, the temperature triggering release of both LBL Lipo-graph and liposome has been
examined in water (Fig. 4E). As shown in Fig. 4E, both liposomes and LBL Lipo-graph nanoparticles
reached a 100% release after 12 min. LBL Lipo-graph nanoparticles demonstrate a slightly slower drug
release rate with 33.53 ± 2.9% release after 2 min and 58.43 ± 6.1% after 4 min. In comparison,
liposomes demonstrate a relatively faster drug release rate with 45.66 ± 3.8% in 2 min and
65.22 ± 3.8% in 4 min. A slower drug release rate may be related to the presence of a protecting shell
around the liposome decreasing the drug diffusion rate to the release media. Irrespective of the
surrounding shells slightly decreasing the drug release rate, it is still sufficiently high to consider as a

good candidate for laser induced thermo-responsive potential application. As supplementary data
(inset picture of Fig. 4E) compares total drug release from LBL Lipo-graph nanoparticles after 20 min at
37, 40, and 42 °C with liposomes. The amount of drug release increases with increasing temperature
due to the acceleration in the phase transitions of the lipid membranes. At all examined temperatures,
the amount of drug release from LBL Lipo-graph nanoparticles is slightly less than liposome due to the
presence of protective shells as discussed earlier.
The data suggests that LBL Lipo-graph nanoparticles offers many benefits to be considered as a good
candidate for chemo-photothermal therapy application including a decrease of the initial burst release
which may result in the reduction in systemic toxicity, increase in the pH responsivity around the
tumor environment and better absorption at NIR regions.

3.7. Stability

The stability of LBL Lipo-graph nanoparticles was explored by monitoring DOX encapsulation efficiency,
size and zeta potential over a one-week time period at 4 °C. Observations suggest that the size and
zeta potential of the nanoparticles changed a little from 267.9 ± 4.6 to 272.8 ± 3.7 nm and 43.9 ± 6.9 to
38.2 ± 4.7 mV, respectively. Encapsulation efficiency didn’t change after one week in part because a
4 °C storage temperature is conducive to preserve LBL Lipo-graph integrity and moreover the
electrostatic shells protects DOX from release into the media.

3.8. Evaluation of LBL Lipo-graph photothermal response at 808 nm

After finding that LBL Lipo-graph has the potential to be considered as a thermo-responsive
nanoparticle, we aimed to test whether thermo-sensitivity could be achieved by utilizing GO and GOPLL to convert light into heat. So, the effect of layer-by-layer assembly of GO and GO-PLL on the
liposome surface on laser induced photothermal response of the nanoparticle was investigated under
NIR pulsed irradiation at different incidence fluence rates (0.5, 1, 1.5 W·cm−2) over a time period of
120 s (Fig. 5A and B). The temperature increase was dependent on the number of layers. For example,
the temperature increase of 1-LBL Lipo-graph, 2-LBL Lipo-graph, 3-LBL Lipo-graph, and 4-LBL Lipo-graph
nanoparticles after 2 min NIR pulse laser irradiation with a power density of 1.5 W·cm−2 was 6.9 ± 1.7,
8.57 ± 1.3, 18.55 ± 1.1, and 26.82 ± 1.7 °C, respectively. However, the temperature increase for
liposome as a control sample is 0.68 ± 0.2 °C. Photothermal response of the LBL Lipo-graph samples
exhibit a power density dependent temperature increase in response to NIR irradiation (Fig. 5A).
Results confirm an improvement in photo-thermal response to laser light, by increasing the graphene
oxide layers on the top of liposomes. Similar effects were observed with other graphene based
materials.31,40

Fig. 5. Photothermal heating curve (A) at various incident NIR laser fluence (0.5, 1, 1.5 W·cm−2) and (B) during
layer by layer construction (1.5 W·cm−2). (C) Cell viability of MD-MB-231 cells after incubation with LBL Lipograph at different DOX concentration. (D) Live/death assay of LBL Lipo-graph treated MD-MB-231 cells observed
with fluorescent microscopy (The scale bar is 200 µm).

3.9. In vitro cytotoxicity assay

To further investigate whether LBL Lipo-graph encapsulated DOX can offer an effective vehicle for
chemo-photothermal therapy, the antitumor effects of LBL Lipo-graph with and without NIR laser
irradiation were examined on MD-MB-231 cell lines. As shown in Fig. 5C, cells were treated with
several concentrations of DOX in the form of free DOX, liposome encapsulated DOX (liposome DOX), 4LBL Lipo-graph encapsulated DOX (LBL Lipo-graph DOX) with and without NIR laser irradiation (2 min,
1.5 W·cm−2). All samples exhibited a concentration-dependent cell toxicity against MD-MB-231 (Fig.
5C).
To visualize the chemo-photothermal therapeutic potential of 4-LBL Lipo-graph on MD-MB-231 cell
lines, cell lines were stained by calcein AM/ EthD–1 (Fig. 5D). Under inverted fluorescence microscope
observation, dead cells exhibit red fluorescence (red channel) while live cells exhibit green
fluorescence (green channels). In the group treated with 4 LBL Lipo-graph nanoparticles the cell death
(red spot) before laser emission corresponded to the chemotherapy effect of DOX while after laser
irradiation increased red spot represents combination of photothermal and chemotherapy targeting
effect of 4-LBL Lipo-graph encapsulated DOX. As shown in Fig. 5D, no difference in toxicity levels were
observed in cell groups treated without any nanoparticles before and after NIR laser irradiation.
The MTT and live/dead assay suggest that 4-LBL Lipo-graph encapsulated DOX (5 µg·ml−1) provide dual
mode targeting: chemotherapy and photothermal action. NIR light absorbed by GO and GO-PLL shells
is converted to heat and activates a gel to liquid phase transition of the liposomal membrane and leads
to release of encapsulated DOX to destroy target tumor cells. Alternatively, light absorbed by GO and
GO-PLL provide photothermal therapeutic effect to kill cancer cells.
Action of both modes are localized to minimize side effects of potential systemic cancer treatment.24

3.10. Cell association with LBL Lipo-graph

Motivated by the effective chemo-photothermal potential of LBL Lipo-graph nanoparticles, we studied
association and number of internalized LBL Lipo-graph capsules per cell by using the image stream flow
cytometry – a single platform combination of flow cytometry and fluorescent microscopy.
Images were recorded in extended depth-of-focus mode which allows a 15 µm depth into the cells and
enabled quantitative analysis of the cells. The analysis was carried out by examining the individual cells
which allows filtering false positive events due to the free capsule while simultaneously passing cells by
the detector.
Interaction between 4-LBL Lipo-graph and cell lines are time dependent (Fig. 6A). Significant
association of 4-LBL Lipo-graph with cells could be observed after several hours, with a maximum
84.9% of association after 24 h suggesting that LBL Lipo-graph binding and uptake is slow. Several
studies have demonstrated that incubation time and surface chemistry have a major effect on
internalization kinetics.85,86,87,88 Although the cellular uptake of graphene oxide is slow as reported by
Zhang et al.,89 the presence of PLL on the nanomaterials surface has shown to an effective mediator on
internalization via binding to anionic groups on a cell surface90 and translocate across the membrane
through an energy dependent clathrin-mediated uptake pathway.91 Alternatively, as the incubation
time increases the chance of absorbing nanoparticles onto the cell membrane for initial internalization
were increased.92,93,94 These observations are consistent with published studies that PLL-coating of
nondiamond, iron oxide and rGO facilitated the cellular uptake in a time dependent manner.95,96,97
However, specifying the exact mechanism of cellular uptake needs further investigation.

Fig. 6. Time-dependent association of FITC labelled LBL Lipo-graph with MD-MB-231 cell lines over 24 h
incubation. (A) Cell percentages associated with MD-MB-231 cells after various incubation times, right y axis
represents an average number of LBL Lipo-graph per cells. (B) LBL Lipo-graph distribution in cells. (C)
Internalization factor monitoring during 24 h incubation. (D) Internalization factor histogram after 24 h
incubation. (E) Upper row represents random cell line image after a time intervals (0, 1.5, 3, 6, 9 and 12 h) and
the lower row represents examples of the cell lines with nanoparticles absorbed which are detected by an image
stream flow cytometer at a particular time frame (0–5 LBL Lipo-graph/cell absorbed) (scale bar is 10 µm).

Image stream flow cytometry revealed that among all the cells associated with LBL Lipo-graph
nanoparticles, an average 6 nanoparticles were endocytosed by the cells after 24 h (Fig. 6A right y-

axis). However, some cells contained larger numbers of nanoparticles (Fig. 6B). Fig. 6B shows how is
the distribution of LBL Lipo-graph inside the MD-MB-231 cell lines.
The high binding and cellular uptake of LBL Lipo-graph may relate to the high positive charge of LBL
Lipo-graph which leads to the presence of GO-PLL on the liposome surface. This high uptake suggested
to provide a sufficient amount of therapeutic drug in the tumorigenic region.

3.11. Distinguishing the fluorescent signal from absorbed LBL Lipo-graph

Image stream flow cytometry with a normal depth of focus has been carried out to discriminate
between internalized and absorbed capsules. A combination of bright field and fluorescent images of
the cells enabled us to determine the internalization factor (IF) by eroding a whole cell mask and an
internalized mask and then comparing them to eliminated fluorescent signals related to the noninternalized nanoparticles. A positive value of IF corresponds to an internalized nanoparticle whereas a
zero value corresponds to the absorbed nanoparticles. Cells with an IF between 0 and 1 represent that
nanoparticles are in the early stage of internalization. Fig. 6C monitored LBL Lipo-graph distribution in
MD-MB-231 cell line after 3, 6, 9, and 24 h and Fig. 6D represented the internalization score after 24 h
treated with LBL Lipo-graph. Fig. 6E upper row represents a random image of cells examined after
various time intervals (0, 1.5, 3, 6, 9 and 12 h) incubation and the lower row shows the presence of 0,
1, 2, 3 and 5 nanoparticles in the cells. As shown in Fig. 6E (upper row) results suggest that after a short
incubation time most nanoparticles were adsorbed on the cell surface without internalization but at
longer times nanoparticles were endocytosed by the cells.
Image stream flow cytometry reveals that the nanoparticles were mainly located on the surface of the
cells in shorter incubation times whereas after 24 h incubation, nanoparticles were found
predominately inside the cells as well as on the cell surface. After 1.5 h, most nanoparticles have a
negative internalized score indicating distribution is outside of the cells and after increasing the
incubation time the negative internalized score decreased and the zero and positive internalized score
increased. Results indicate movement of nanoparticles inside the cells. Understanding the main
process of cellular internalization of LBL Lipo-graph will be helpful to further optimize the drug carriers
for effective drug delivery.

3.12. Confocal microscopy imaging

Further characterization of LBL Lipo-graph distribution inside the cells was obtained by confocal laser
scanning microscopy (Fig. 7). MD-MB-231 cells were incubated with rhodamine encapsulated LBL Lipograph at various incubation times. Confocal microscopy showed time dependent and highly efficient
intracellular delivery of LBL Lipo-graph nanoparticles. As shown in Fig. 7A, after 24 h incubation, MDMB-231 cells shows red dot fluorescence in the cytoplasm and nuclei, suggesting that LBL Lipo-graph
were taken up by both cytoplasm and nuclei. The data was consistent with image stream flow
cytometry analysis. Results indicate the presence of highly positive charged GO-PLL in the outer layers
of LBL Lipo-graph increase cellular internalization over a time.

Fig. 7. The intracellular uptake of LBL Lipo-graph by MD-MB-231 cell lines was observed by confocal microscopy
after 0, 1.5, 3, 6, 9 and 24 h incubation. The images obtained in the left column shows the cells and the right
column represent the cells with LBL Lipo-graph internalization. The inset in the right column shows a zoomedout version of the nanoparticles in the corresponding images. It is to be noted that colour changes occur during
hyper-stacking of the images from different channels of the two photon microscope, Blue: nuclei, Green:
cytoplasm, Red: LBL Lipo-graph, (scale bar is 100 µm). (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)

4. Conclusion
LBL Lipo-graph encapsulated doxorubicin, a dual chemo-photothermal therapeutic platform, was
successfully prepared by layer-by-layer deposition of GO and GO-PLL on the surface of cationic
liposomes. The GO and GO-PLL on the liposome function as a photothermal transducer (a light

absorber and heat generating agent). The deposition of these layers was governed by electrostatic
attraction. The successful layer-by-layer construction was dependent on GO and GO-PLL
concentrations. As the number of layers increase the coating becomes more difficult to construct,
requiring more precise adjustment of GO and GO-PLL concentrations. The fabrication of LBL Lipo-graph
was monitored using DLS and zeta potential analysis. The thermal behaviour and morphology of the
nanoparticles were analysed by TGA, DSC, TEM and SEM. Furthermore, IR camera imaging was
performed to determine how many layers are accurately needed to achieve a desired photothermal
response. Also, light matter interaction of LBL Lipo-graph with 808 nm laser was examined by
measuring absorption cross section. The drug release assay of LBL Lipo-graph demonstrated the
thermosensitivity and pH sensitivity of the nanoparticles. The toxicity assay showed that LBL Lipograph can effectively destroy MD-MB-231 cells upon NIR irradiation. The presence of GO-PLL in the
outer layer of LBL Lipo-graph can increase the cellular uptake and can also increase chance of drug
accumulation inside the cells. Moreover, the presence of a large number of functional groups on the
GO-PLL provides an effective binding platform for active targeting of LBL Lipo-graph. We anticipate that
the present system could be designed for co-delivery of multiple therapeutic agent for effective dual
chemo-photothermal treatment.
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